Reuters Market Eye - Pharmaceutical stocks slump - Glenmark Pharmaceutical falls 6 pct, Aurobindo Pharma slumps 6.8 pct, Lupin loses 5.3 pct. Ranbaxy Laboratories down 4 pct, Cipla loses 3.6 pct, Sun Pharmaceutical Industries trading 3.4 pct lower. Dr. Reddy's Laboratories drops 2.2 pct.
Currency crisis in emerging markets could result in earnings downgrades, analysts say.
Higher export realisation due to rupee depreciation may get cancelled due to forex hedges and slowdown in other markets
Impact of currency depreciation in Russia, CIS and Latin America on FY16 earnings
Dr.Reddy -4.9
Glenmark -3.8
Also Read
Ranbaxy -3.3
Source: Motilal Oswal
(Reporting by Abhishek Vishnoi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app